Refusals After Prehospital Administration of Naloxone during the COVID-19 Pandemic.
Prehospital Emergency Care · 2020-10-16 · Observational study
Abstract
OBJECTIVE: To determine if COVID-19 was associated with a change in patient refusals after Emergency Medical Services (EMS) administration of naloxone. METHODS: This is a retrospective cohort study in which the incidence of refusals after naloxone administration in a single EMS system was evaluated. The number of refusals after naloxone administration was compared across the before-pandemic interval (01/01/20 to 02/15/20) and the during-pandemic interval (03/16/20 to 04/30/20). For comparison the incidence of all other patient refusals before and during COVID-19 as well as the incidences of naloxone administration before and during COVID-19 were also reported. RESULTS: Prior to the widespread knowledge of the COVID-19 pandemic, 24 of 164 (14.6%) patients who received naloxone via EMS refused transport. During the pandemic, 55 of 153 (35.9%) patients who received naloxone via EMS refused transport. Subjects receiving naloxone during the COVID-19 pandemic were at greater risk of refusal of transport than those receiving naloxone prior to the pandemic (RR = 2.45; 95% CI 1.6-3.76). Among those who did not receive naloxone, 2067 of 6956 (29.7%) patients were not transported prior to the COVID-19 pandemic and 2483 of 6016 (41.3%) were not transported during the pandemic. Subjects who did not receive naloxone with EMS were at greater risk of refusal of transport during the COVID-19 pandemic than prior to it (RR = 1.39; 95% CI 1.32-1.46). CONCLUSION: In this single EMS system, more than a two-fold increase in the rate of refusal after non-fatal opioid overdose was observed following the COVID-19 outbreak.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antidotes · Naloxone · COVID-19 pandemic
Related articles
- Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review. (Reg Anesth Pain Med, 2023)
- Nonfatal opioid-related overdoses treated by emergency medical services in Florida, before and during the COVID-19 pandemic. (Prev Med Rep, 2023)
- Importance of Analyzing Intervals to Emergency Medical Service Treatments. (Prehosp Emerg Care, 2023)
- Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study. (JMIR Public Health Surveill, 2021)
- Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey. (J Addict Med, 2020)
- Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis. (J Urban Health, 2020)